Evidence map›Paper›PMID 29675431›Full record

ArticleJournal of diabetes research2018

Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes.

Anna Tedeschi, Alessandra De Bellis, Piergiorgio Francia, Arianna Bernini, Marco Perini, Elisabetta Salutini, Roberto Anichini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna TedeschiDiabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, Pistoia, Italy.
Alessandra De BellisDiabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, Pistoia, Italy.
Piergiorgio FranciaDepartment of Clinical and Experimental Medicine, School of Human Health Sciences, Florence, Italy.
Arianna BerniniDiabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, Pistoia, Italy.
Marco PeriniDiabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, Pistoia, Italy.
Elisabetta SalutiniDiabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, Pistoia, Italy.
Roberto AnichiniDiabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, Pistoia, Italy.ORCID 0000-0002-8227-9388
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study has been performed in diabetic type 2 patients with pain due to peripheral artery disease (PAD) in order to evaluate the efficacy and tolerability of tapentadol prolonged release (PR).

Indexed as

AgedAged, 80 and overAnalgesicsChronic PainDelayed-Action PreparationsDiabetes Mellitus, Type 2Diabetic AngiopathiesFemaleHumansMaleMiddle AgedPainPain MeasurementPeripheral Arterial DiseasePhenolsQuality of LifeAnalgesicsDelayed-Action PreparationsPhenolsTapentadol

Identifiers

PMID29675431
PMCPMC5838502
OpenAlexW2791610781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.